Codice QR

PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults

The pharmacologic inhibition of proprotein convertase subtilisin-kexin type 9 (PCSK9) lowers lipoprotein (a) [Lp(a)] concentrations. However, the impact of genetic PCSK9 loss-of-function variants (LOFVs) on Lp(a) is uncertain. We determined the association of PCSK9 LOFVs with Lp(a) measures among bl...

Descrizione completa

Salvato in:
Autori principali: Matthew T. Mefford, Santica M. Marcovina, Vera Bittner, Mary Cushman, Todd M. Brown, Michael E. Farkouh, Sotirios Tsimikas, Keri L. Monda, J. Antonio G. López, Paul Muntner, Robert S. Rosenson
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2019-11-01
Serie:Journal of Lipid Research
Soggetti:
proprotein convertase subtilisin-kexin type 9
lipoprotein (a)
apolipoprotein
oxidized phospholipids
epidemiology
Accesso online:http://www.sciencedirect.com/science/article/pii/S0022227520322926
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi